Watching GoodRx Holdings, Inc.? See every signal — funding, hires, M&A, contracts, sentiment.
Book a demoChoose your planFunding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →
Back to SEC FilingsExecutive ChangeItem 5.02 · 8-KMEDIUM RiskNeutral
GoodRx Holdings, Inc.
www.goodrx.comFiled: Jul 31, 2026CIK: 0001809519Software
AI Executive Summary
AI-powered analysis of 8-K filing content
GoodRx Holdings announced that Chief Financial Officer & Treasurer Christopher McGinnis will transition from his role effective August 5, 2026. The departure is not due to disagreements regarding operations or financial practices, but represents a significant change in financial leadership that could impact investor confidence and strategic direction.
Key Takeaways
Christopher McGinnis is departing as CFO & Treasurer effective August 5, 2026 at 11:59 p.m. ET
The company explicitly stated the departure is not due to any disagreements regarding operations or financial reporting
2 more takeaways
Filing Overview
Form Type8-K
Filing DateJul 31, 2026
Item5.02
CategoryExecutive Change
CIK0001809519
Accession #gdrx-20260731
Risk LevelMEDIUM
SentimentNeutral
Signalinformational
Topics
leadership transitionexecutive departure
What This Means
A senior executive (CEO, CFO, etc.) has joined, departed, or changed roles. Leadership changes can significantly impact strategy.